Relationship between public subsidies and vaccination rates with the 23-valent pneumococcal vaccine in elderly persons, including the influence of the free vaccination campaign after the Great East Japan Earthquake

Journal of Infection and Chemotherapy

Volumn 20, Issue 7, 2014, Pages 450-453

  Naito, Toshio ^a   Matsuda, Naoto ^a   Tanei, Mika ^a   Watanabe, Yukiko ^a   Watanabe, Akira ^b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Disaster; Health care costs; Pneumococcal vaccine; Public subsidies

Indexed keywords

PNEUMOCOCCUS VACCINE; 23-VALENT PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE VACCINE;

ARTICLE; DISASTER VICTIM; EARTHQUAKE; HEALTH CARE COST; HUMAN; JAPAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); REIMBURSEMENT; STREPTOCOCCUS PNEUMONIA; VACCINATION; AGE; AGED; ECONOMICS; FINANCIAL MANAGEMENT; IMMUNOLOGY; PROCEDURES;

AGE FACTORS; AGED; EARTHQUAKES; FINANCING, GOVERNMENT; HUMANS; JAPAN; PNEUMOCOCCAL VACCINES; VACCINATION;

EID: 84903747241     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2014.03.004     Document Type: Article

References (14)

1. Percentage of adults aged 65 years and over who had ever received a pneumococcal vaccination: United States.http://www.cdc.gov/nchs/data/nhis/ earlyrelease/201009-05.pdf; 1997eMarch 2010.
2. http://www.e-stat.go.jp/SG1/estat/GL08020103.do?-toGL08020103- &tclassID=000001048449&cycleCode=0&requestSender=search.
3. http://www.e-stat.go.jp/SG1/estat/NewList.do?tid=000000090001.
4. Maruyama T, Taguchi O, Niederman MS, Morser J, Kobayashi H, Kobayashi T, et al. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. BMJ 2010;340:c1004.
5. Hung IF, Leung AY, Chu DW, Leung D, Cheung T, Chan CK, et al. Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study. Clin Infect Dis 2010;51: 1007-16.
6. Kawakami K, Ohkusa Y, Kuroki R, Tanaka T, Koyama K, Harada Y, et al. Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan. Vaccine 2010;28: 7063-9.
7. http://nk.jiho.jp/servlet/nk/release/pdf/1226504257307.
8. Kondo M, Yamamura M, Hoshi SL, Okubo I. Demand for pneumococcal vaccination under subsidy program for the elderly in Japan. BMC Health Serv Res 2012;12:313.
9. Matsumoto K, Kamiya H, Nagai H, Uchiyama B, Murakami T, Furuta S, et al. Survey of patients who were vaccinated pneumococcal vaccine at the 11 cities, towns and villages which are partially subsidizing pneumococcal vaccination cost. Antibiot Chemother Jpn 2008;24: 110-22.
10. Infectious Agents surveillance report. (http://idsc.nih.go.jp/iasr/32/ 32s/ mp32s4.html).
11. Naito T. An initiative offering free pneumococcal vaccination to victims of the Great East Japan earthquake. Thorax 2013;68: 1068-9.
12. Takahashi H, Fujimura S, Ubukata S, Sato E, Shoji M, Utagawa M, et al. Pneumonia after earthquake, Japan, 2011. Emerg Infect Dis 2012;18: 1909-11.
13. Daito H, Suzuki M, Shiihara J, Kilgore PE, Ohtomo H, Morimoto K, et al. Impact of the Tohoku earthquake and tsunami on pneumonia hospitalisations and mortality among adults in northern Miyagi, Japan: a multicentre observational study. Thorax 2013;68: 544-50.
14. Oishi K. A report of health and labour sciences research grant research on emerging and re-emerging infectious diseases. (https://mhlw-grants.niph.go. jp/niph/search/NIDD00.do?resrchNum=201225066A).